Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines

Susan M. Chang, Hans Messersmith, Manmeet Ahluwalia, David Andrews, Priscilla K. Brastianos, Laurie E. Gaspar, Na Tosha N. Gatson, Justin T. Jordan, Mustafa Khasraw, Andrew B. Lassman, Julia Maues, Maciej Mrugala, Jeffrey Raizer, David Schiff, Glen, Do, Phd Stevens, Ashley Sumrall, Martin Van Den Bent, Michael A. Vogelbaum

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

PURPOSE The Congress of Neurological Surgeons (CNS) has developed a series of guidelines for the treatment of adults with metastatic brain tumors, including systemic therapy and supportive care topics. ASCO has a policy and set of procedures for endorsing clinical practice guidelines that have been developed by other professional organizations. METHODS Two CNS guidelines were reviewed for developmental rigor by methodologists, and an independent multidisciplinary Expert Panel was formed to review the content and assess agreement with the recommendations. The Expert Panel voted to endorse the two guidelines, and ASCO and Society for Neuro-Oncology (SNO) independently reviewed and approved the ASCO/SNO guideline endorsement. RESULTS The ASCO/SNO Expert Panel determined that the recommendations from the CNS anticonvulsants and steroids guidelines, published January 9, 2019, are clear, thorough, and based on the most relevant scientific evidence. ASCO/SNO endorsed these two CNS guidelines with minor alterations. RECOMMENDATIONS Key recommendations include the following: prophylactic antiepileptic drugs were not recommended for routine use; and corticosteroids, specifically dexamethasone, were recommended for temporary symptomatic relief in patients with neurologic symptoms and signs related to mass effect from brain metastases. Additional information is available at www.asco.org/neurooncology-guidelines.

Original languageEnglish (US)
Pages (from-to)1130-1135
Number of pages6
JournalJournal of Clinical Oncology
Volume37
Issue number13
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines'. Together they form a unique fingerprint.

  • Cite this

    Chang, S. M., Messersmith, H., Ahluwalia, M., Andrews, D., Brastianos, P. K., Gaspar, L. E., Gatson, N. T. N., Jordan, J. T., Khasraw, M., Lassman, A. B., Maues, J., Mrugala, M., Raizer, J., Schiff, D., Stevens, G. D. P., Sumrall, A., Van Den Bent, M., & Vogelbaum, M. A. (2019). Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines. Journal of Clinical Oncology, 37(13), 1130-1135. https://doi.org/10.1200/JCO.18.02085